PolitMaster.com is a comprehensive online platform providing insightful coverage of the political arena: International Relations, Domestic Policies, Economic Developments, Electoral Processes, and Legislative Updates. With expert analysis, live updates, and in-depth features, we bring you closer to the heart of politics. Exclusive interviews, up-to-date photos, and video content, alongside breaking news, keep you informed around the clock. Stay engaged with the world of politics 24/7.
You’re probably well aware of your personality type, like whether you’re an introvert or extrovert. You might even know your love language. But have you ever considered your sleep type?
The world spent more on military costs and weapons in 2023 than it had in 35 years, driven in part by the war in Ukraine and the threat of an expanded Russian invasion, according to an independent analysis released on Monday.
The rate of emergency room visits caused by heat illness increased significantly last year in large swaths of the country compared with the previous five years, according to a study published on Thursday by the Centers for Disease Control and Prevention.
WASHINGTON (AP) — Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns.
A new study confirms what election experts have been warning about for years: increased harassment and threats following the 2020 election have led election officials to quit at higher rates than in previous election cycles.
Every parent’s wish is for their child to grow up and live a fulfilled, happy life. During the teen years, this desire often leads to a laser-like focus on grades, test scores and the chances of college admission. After all, happiness is hard to come by without the economic security of a steady paycheck. But what if it isn’t a young person’s grades, but the kind of thinking they’re doing — in and outside of school — that sets them up for a happy adulthood?
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.